Strength
160 mg/mL
Manufacturer
UCB, Inc.NDC
50474078185
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/1/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
10/17/2023
Price Statistics
The NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has been published 49 times since Sep 17, 2025, and over the history we have for it it has risen 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8112.5853 per ML |
|---|---|
| All-time high | $8112.5853 (Aug 19, 2026) |
| All-time low | $7696.9500 (Dec 17, 2025) |
| 52-week high | $8112.5853 |
| 52-week low | $7696.9500 |
| Median price | $8112.5853 |
| Average price | $7969.9336 |
| Largest weekly change | +5.4% (Jan 14, 2026) |
| Weeks tracked | 49 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BIMZELX 160 MG/ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for BIMZELX 160 MG/ML AUTOINJECTOR, manufactured by UCB, Inc., is $8112.5853 per ML (NDC 50474078185), effective Aug 19, 2026.
How has the price of BIMZELX 160 MG/ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has risen 5.3%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for BIMZELX 160 MG/ML AUTOINJECTOR?
Since Sep 17, 2025, the NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has ranged from a low of $7696.9500 (Dec 17, 2025) to a high of $8112.5853 (Aug 19, 2026), with a median of $8112.5853 per ML.
Are there cheaper alternatives to BIMZELX 160 MG/ML AUTOINJECTOR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BIMZELX 160 MG/ML AUTOINJECTOR, is $8035.0733 per ML — about 1% below BIMZELX 160 MG/ML AUTOINJECTOR.
Who manufactures BIMZELX 160 MG/ML AUTOINJECTOR?
BIMZELX 160 MG/ML AUTOINJECTOR (NDC 50474078185) is labeled by UCB, Inc., and CMS classifies it as a brand product.